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In the original article \[[@CR1]\] the first paragraph of the Background section was omitted due to a discrepancy between the metadata of the article and the PDF version. This Correction article shows the missing paragraph of the Background section. The original article has been updated.

**Background** {#Sec1}
==============

Globally, cervical cancer is the fourth most common cancer in women with more than 85% of the burden in developing countries \[1\]. The majority of cervical cancer mortality occurs in developing countries, where screening and optimal treatment are not adequately available \[2\]. Cancer of the cervix constituted 22.2% of all cancers among women in Sub-Saharan Africa in 2012 \[3\]. In Uganda, cervical cancer is the number one cancer killer disease among women, this is followed by breast cancer \[4\]. With the incidence standing at 52 /100,000 women of reproductive age, it is one of the highest globally. Regrettably, more than half of these women die every year \[5, 6\]. The Kampala cancer registry shows that Uganda has an age standardized incidence rate of 47.5 per 100,000 against the global estimate of 15.8 per 100,000 \[7\]. Many of the Cervical cancer cases present with an advanced stage of the disease \[8\].
